Concept - Product - Mission
SensArs is changing peripheral neurostimulation – SensArs has developed a novel neurostimulator that can be implanted in a ‘click’ transversely inside the nerve
Sponsors, awards and prizes
AWARDS and prizes
Check out our latest news and stories
SensArs has been granted FDA Breakthrough Device Designation for SENSY
SensArs is proud to announce that on August 11, 2021, FDA granted Breakthrough Device Designation for our SENSY System! This is a huge step towards SensArs’ mission of bringing relief to those suffering from chronic peripheral neuropathic pain and/or sensory loss and is indicated for persons over 18, providing sensory feedback for those with limb loss to improve prosthesis function.
SensArs has been awarded with a DIH-HERO Technology Transfer Experiment Grant for treating chronic neuropathic pain
“The major aim of this call is to stimulate the transfer of innovative technology from outside the robotics and healthcare domains, to solve unanswered clinical questions.” Read more here.
Our CEO, Francesco Petrini, was nominated among the 35 innovators under 35, from MIT
Although orthopaedics are already highly mobile, they cannot replicate the feeling of having a real leg. To address this problem, SensArs Neuroprosthetics founder, Francesco Petrini, has developed SENSY.
SensArs coordinates a consortium of 4 partners coming from 4 countries to take to market its product SENSY
SensArs Neuroprosthetics coordinates a 3 million EUR grant to develop and test its product that restores life-like sensations from the prosthesis of leg amputees SensArs Neuroprosthetics announces the start of a project financed by the European Union’s Horizon 2020 research and innovation programme under grant agreement No 870144. The European Commission will give a[…]
SensArs financed from the European Commission to explore the feasibility of stimulating the vagal nerve
SensArs, within a consortium of 6 partners coming from 5 countries, was financed from the European Commission to explore the feasibility of stimulating the vagal nerve to control the heartbeat of patients who underwent heart transplantation. The project is called NeuHearth (Grant agreement ID: 824071). More information can be found here.
SensArs among the successful stories mentioned by the EIT Health
SensArs among the successful stories mentioned by the EIT Health. Check the link
SensArs is one of the 4 Startups selected for the EIT Health Germany Headstart Awards 2018
SensArs is one of the 4 Startups selected for the EIT Health Germany Headstart Awards 2018 – valued at €50,000 each – to accelerate their entry to market. Read here the news from EIT Health.
SensArs among the successful stories mentioned by the European Commission
SensArs among the successful stories mentioned by the European Commission. Check the link
SensArs project is recommended for funding by European Commission
Click here to view full document.
Ten start-ups selected for the venture leaders Life Science program in Boston
“The venture leaders Life Science program is a one-week investors and business roadshow in Boston, co-organized with swissnex Boston. This year’s winners develop amazing technologies such as a prosthesis which allows amputees to naturally feel their missing limbs again or an ingeniously simple approach to computed guided needle navigation in the body.”